These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 1595392)

  • 21. Detection of progesterone receptor and the correlation with Ki-67 labeling index in meningiomas.
    Mukherjee S; Ghosh SN; Chatterjee U; Chatterjee S
    Neurol India; 2011; 59(6):817-22. PubMed ID: 22234191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term follow up of progesterone receptor status in benign meningioma: a prognostic indicator of recurrence?
    Fewings PE; Battersby RD; Timperley WR
    J Neurosurg; 2000 Mar; 92(3):401-5. PubMed ID: 10701525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gonadotropin-releasing hormone (GnRH) and its receptor in human meningiomas.
    Hirota Y; Tachibana O; Uchiyama N; Hayashi Y; Nakada M; Kita D; Watanabe T; Higashi R; Hamada J; Hayashi Y
    Clin Neurol Neurosurg; 2009 Feb; 111(2):127-33. PubMed ID: 18980792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical identification and image analysis quantification of oestrogen and progesterone receptors in canine and feline meningioma.
    Mandara MT; Ricci G; Rinaldi L; Sarli G; Vitellozzi G
    J Comp Pathol; 2002; 127(2-3):214-8. PubMed ID: 12354535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estrogen and progesterone receptors in meningiomas and gliomas.
    Georgakulias N; Singounas E; Kypriades E; Giotis J; Karvounis P
    Zentralbl Neurochir; 1993; 54(3):139-42. PubMed ID: 8237168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogen and progesterone receptors in meningiomas.
    Cahill DW; Bashirelahi N; Solomon LW; Dalton T; Salcman M; Ducker TB
    J Neurosurg; 1984 May; 60(5):985-93. PubMed ID: 6716168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progestin and oestrogen receptors in meningiomas. Biochemical characterization, clinical and pathological correlations in 42 cases.
    Magdelenat H; Pertuiset BF; Poisson M; Martin PM; Philippon J; Pertuiset B; Buge A
    Acta Neurochir (Wien); 1982; 64(3-4):199-213. PubMed ID: 7136865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Steroid hormone and epidermal growth factor receptors in meningiomas.
    Horsfall DJ; Goldsmith KG; Ricciardelli C; Skinner JM; Tilley WD; Marshall VR
    Aust N Z J Surg; 1989 Nov; 59(11):881-8. PubMed ID: 2818349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogen and progesterone receptors in meningiomas in relation to clinical and pathologic features.
    Markwalder TM; Zava DT; Goldhirsch A; Markwalder RV
    Surg Neurol; 1983 Jul; 20(1):42-7. PubMed ID: 6867927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The double immunostaining of CD133 and Ki-67 favours a significant co-localization pattern in fibroblastic subtype of meningiomas.
    Albayrak BS; Ismailoglu O; Tanriover G; Cetinalp EN; Demir N
    Neurol Neurochir Pol; 2011; 45(5):467-73. PubMed ID: 22127942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic indicators.
    Sarkar A; Chiocca EA
    J Neurosurg; 2006 Aug; 105(2):161-2; discussion 162. PubMed ID: 17219817
    [No Abstract]   [Full Text] [Related]  

  • 32. The presence of progesterone receptors in arachnoid granulations and in the lining of arachnoid cysts: its relevance to expression of progesterone receptors in meningiomas.
    Verhagen A; Go KG; Visser GM; Blankenstein MA; Vaalburg W
    Br J Neurosurg; 1995; 9(1):47-50. PubMed ID: 7786426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meningioma: proliferating potential and clinicoradiological features.
    Nakasu S; Nakajima M; Matsumura K; Nakasu Y; Handa J
    Neurosurgery; 1995 Dec; 37(6):1049-55. PubMed ID: 8584144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progesterone receptor expression and Ki-67 labelling index of meningiomas in the Lagos university teaching hospital.
    Ikeri NZ; Anunobi CC; Bankole OB
    Niger Postgrad Med J; 2018; 25(1):17-20. PubMed ID: 29676340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progesterone-receptor index in meningiomas: correlation with clinico-pathological parameters and review of the literature.
    Wolfsberger S; Doostkam S; Boecher-Schwarz HG; Roessler K; van Trotsenburg M; Hainfellner JA; Knosp E
    Neurosurg Rev; 2004 Oct; 27(4):238-45. PubMed ID: 15168138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is progesteron receptor status really a prognostic factor for intracranial meningiomas?
    Iplikcioglu AC; Hatiboglu MA; Ozek E; Ozcan D
    Clin Neurol Neurosurg; 2014 Sep; 124():119-22. PubMed ID: 25036873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Noninvasive evaluation of the malignant potential of intracranial meningiomas performed using proton magnetic resonance spectroscopy.
    Shino A; Nakasu S; Matsuda M; Handa J; Morikawa S; Inubushi T
    J Neurosurg; 1999 Dec; 91(6):928-34. PubMed ID: 10584837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogen and progesterone receptors in human meningiomas: biochemical and immunocytochemical evaluation.
    Bozzetti C; Camisa R; Nizzoli R; Manotti L; Guazzi A; Naldi N; Mazza S; Nizzoli V; Cocconi G
    Surg Neurol; 1995 Mar; 43(3):230-3; discussion 234. PubMed ID: 7792684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inverse correlation of cell proliferation and expression of progesterone receptors in tumor spheroids and monolayer cultures of human meningiomas.
    Tonn JC; Ott MM; Bouterfa H; Kerkau S; Kapp M; Müller-Hermelink HK; Roosen K
    Neurosurgery; 1997 Nov; 41(5):1152-9. PubMed ID: 9361071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proliferation and progesterone receptor status in benign meningiomas are not age dependent.
    Roser F; Nakamura M; Ritz R; Bellinzona M; Dietz K; Samii M; Tatagiba MS
    Cancer; 2005 Aug; 104(3):598-601. PubMed ID: 15952201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.